Add Company
Join Now

PDC*line Pharma Revenue and Competitors

License our Company Data API

Liège, fr

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • PDC*line Pharma has 40 Employees.(i)
  • PDC*line Pharma grew their employee count by 5% last year.

PDC*line Pharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A52136%N/AN/A
#2
N/A8326%N/AN/A
#3
N/A18821%N/AN/A
#4
N/A141152%N/AN/A
#5
N/A7267%N/AN/A
#6
N/A9125%N/AN/A
#7
N/A405%N/AN/A
#8
N/A41141%N/AN/A
#9
N/A270%N/AN/A
#10
N/A6N/AN/AN/A
Add Company

What Is PDC*line Pharma?

PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells (PDC*line). Based on a robust preclinical package and a first-in-human phase Ib in melanoma, PDC*line Pharma reported promising Phase I/II results in lung cancer (PDC*lung) in 2024. Preparations are now underway for a randomized Phase II trial in lung cancer, and a Phase Ib trial in colorectal cancer with neoantigens (PDC*neo). The company has raised €61M in equity and non-dilutive funding and signed a €108M licensing deal in Asia with the Korean pharmaceutical company, LG Chem Life Science.

keywords:N/A

N/A

Total Funding

40

Number of Employees

N/A

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A5150%N/A
#2
$5.8M5432%N/A
#3
$10.9M6018%N/A
#4
$10.2M6313%N/A
#5
$9.8M63-10%N/A